**Note 1:** When both the Federation Internationale de Gynecologie et d'Obstetrique (FIGO) stage and metastatic detail are available, record the code with metastatic detail in preference to a statement of FIGO stage.
**Note 2:** EOD Mets excludes metastasis to the vagina (See EOD Primary Tumor) or to the pelvic or paraaortic nodes (See EOD Regional Nodes)
(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998
(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.
(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL)
(4) **Cervix Uteri**, from the AJCC Cancer Staging System Version 9 (2020). Used with permission of the American College of Surgeons, Chicago, Illinois.